ICON PLC Logo

ICON PLC

Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.

ICLR | US

Overview

Corporate Details

ISIN(s):
IE0005711209 (+1 more)
LEI:
Country:
United States of America
Address:
SOUTH COUNTY BUSINESS PARK, 0 DUBLIN 18
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ICON PLC is a global healthcare intelligence and clinical research organization (CRO) that provides outsourced development and commercialization services. The company partners with pharmaceutical, biotechnology, and medical device industries, offering a comprehensive suite of solutions that span the product lifecycle, from molecule to medicine. Key services include clinical development, bioanalytical and specialty laboratory solutions, patient-centric trial recruitment, cardiac safety monitoring, and strategic consulting on market access, pricing, and reimbursement. ICON specializes in providing bespoke, integrated solutions to support drug and device development strategies for its clients worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ICON PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ICON PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ICON PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America
IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America
IBTA
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America
IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea
456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America
IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America
IMUX
IMMUTEP Ltd Logo
Developing LAG-3-based immunotherapies for cancer and autoimmune diseases.
United States of America
IMMP
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan
6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea
101140
Incannex Healthcare Inc. Logo
Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.
United States of America
IXHL

Talk to a Data Expert

Have a question? We'll get back to you promptly.